EPM
Equitec Proprietary Markets’s Alaunos Therapeutics TCRT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,023
| Closed | -$644 | – | 102 |
|
|
2023
Q1 | $644 | Hold |
1,023
| – | – | ﹤0.01% | 95 |
|
|
2022
Q4 | $664 | Hold |
1,023
| – | – | ﹤0.01% | 119 |
|
|
2022
Q3 | $2K | Hold |
1,023
| – | – | ﹤0.01% | 140 |
|
|
2022
Q2 | $1K | Hold |
1,023
| – | – | ﹤0.01% | 174 |
|
|
2022
Q1 | $1K | Hold |
1,023
| – | – | ﹤0.01% | 180 |
|
|
2021
Q4 | $1K | Buy |
+1,023
| New | +$1K | ﹤0.01% | 359 |
|
|
2021
Q3 | – | Sell |
-12,028
| Closed | -$32K | – | 228 |
|
|
2021
Q2 | $32K | Buy |
+12,028
| New | +$32K | 0.01% | 129 |
|
|
2020
Q4 | $13K | Sell |
4,976
-1,924
| -28% | -$5.03K | ﹤0.01% | 59 |
|
|
2020
Q3 | $17K | Buy |
+6,900
| New | +$17K | 0.01% | 43 |
|
|
2020
Q1 | $16K | Buy |
+4,528
| New | +$16K | 0.01% | 182 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 25 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 29 |
|
|
2018
Q2 | – | Sell |
-20,342
| Closed | -$80K | – | 42 |
|
|
2018
Q1 | $80K | Sell |
20,342
-43,753
| -68% | -$172K | 0.02% | 23 |
|
|
2017
Q4 | $265K | Buy |
64,095
+3,623
| +6% | +$15K | 0.08% | 17 |
|
|
2017
Q3 | $371K | Buy |
60,472
+26,345
| +77% | +$162K | 0.09% | 19 |
|
|
2017
Q2 | $212K | Buy |
+34,127
| New | +$212K | 0.05% | 29 |
|
|
2017
Q1 | – | Sell |
-52,593
| Closed | -$281K | – | 53 |
|
|
2016
Q4 | $281K | Buy |
52,593
+42,498
| +421% | +$227K | 0.01% | 29 |
|
|
2016
Q3 | $57K | Buy |
10,095
+6,095
| +152% | +$34.4K | ﹤0.01% | 46 |
|
|
2016
Q2 | $22K | Buy |
+4,000
| New | +$22K | ﹤0.01% | 57 |
|